Search

Your search keyword '"Boris Mankovsky"' showing total 54 results

Search Constraints

Start Over You searched for: Author "Boris Mankovsky" Remove constraint Author: "Boris Mankovsky"
54 results on '"Boris Mankovsky"'

Search Results

1. CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

2. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

3. Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

4. An elevated serum level of endothelial monocyte activating polypeptide-II in patients with arterial hypertension with and without type 2 diabetes and obesity

5. Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

6. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society

7. Diabetes and stroke

8. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

10. The role of hyperglycemia in the course of strokes in patients with diabetes

11. Editorial commentary to manuscript 'Neural correlates of slower gait in middle-aged persons with childhood-onset type 1 diabetes mellitus: The impact of accelerated brain aging' by Royse et al

12. Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs

14. Diabetes Care at the Times of Transition and COVID-19 Pandemics (Ukrainian Experience)

15. Risk factors cardiovascular autonomi c neuropathy in type 2 diabetes mellitus

16. Cognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus

17. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

18. Relationship between diabetic retinopathy and cerebral perfusion in type 2 diabetes mellitus

19. Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy

20. Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study

21. Characteristics of cognitive function in patients with diabetes mellitus type 1 younger depending transferred hypoglycemic conditions

22. The relationship between cognitive impairment and decreased cerebral blood flow in the frontal area

23. Serum levels of endothelial monocyte activating polypeptide-II in type 1 diabetes patients with microangyopathy and arterial hypertention

24. CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle

25. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

26. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries

28. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

29. The Content of Blood Leptin and Activity of Systemic Inflammatory Response in Patients with Type 2 Diabetes Mellitus depending on Weight and Length of the Process

31. Antihypertensive Treatment and Kidney Function in Routine Practice in Patients with Type 2 Diabetes Mellitus: The Results of the Prospective 'The Scythian' Trial in Ukraine

32. Morphology of bronchial epithelium in rodent streptozotocin-induced diabetes mellitus

33. Correlation between arterial wall stiffness, N-terminal prohormone of brain natriuretic peptide, functional and structural myocardial abnormalities in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy

34. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

35. Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine

37. 4th Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12–14, 2011, Budapest, Hungary

38. Is serum uric acid a risk factor for atherosclerotic cardiovascular disease?

39. Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients

40. Glitazones: Beyond glucose lowering!

41. The INTERPRET-DD study of diabetes and depression: a protocol

42. Impairment of cerebral autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic hypotension

43. Case 42: The Slow Progression of Type 1 Diabetes as Part of Autoimmune Polyendocrine Syndrome Type 2

44. The size of subcortical ischemic infarction in patients with and without diabetes mellitus

45. Abstract # PO-1: Association Between Structural Brain Abnormalities and Cognitive Functioning in Patients with Type 2 Diabetes Mellitus

47. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

48. Cerebrovascular disorders in patients with diabetes mellitus

49. Benfotiamine: Commentary and update on recent studies

Catalog

Books, media, physical & digital resources